Lancet Public Health. 2024 Aug;9(8):e551-e563. doi: 10.1016/S2468-2667(24)00131-2. Epub 2024 Jul 14.
Cirrhosis is responsible for substantial health and economic burden in the USA. Reducing this burden requires better understanding of how rates of cirrhosis mortality vary by race and ethnicity and by geographical location. This study describes rates and trends in cirrhosis mortality for five racial and ethnic populations in 3110 US counties from 2000 to 2019.
We estimated cirrhosis mortality rates by county, race and ethnicity, and year (2000-19) using previously validated small-area estimation methods, death registration data from the US National Vital Statistics System, and population data from the US National Center for Health Statistics. Five racial and ethnic populations were considered: American Indian or Alaska Native (AIAN), Asian or Pacific Islander (Asian), Black, Latino or Hispanic (Latino), and White. Cirrhosis mortality rate estimates were age-standardised using the age distribution from the 2010 US census as the standard. For each racial and ethnic population, estimates are presented for all counties with a mean annual population greater than 1000.
From 2000 to 2019, national-level age-standardised cirrhosis mortality rates decreased in the Asian (23·8% [95% uncertainty interval 19·6-27·8], from 9·4 deaths per 100 000 population [8·9-9·9] to 7·1 per 100 000 [6·8-7·5]), Black (22·8% [20·6-24·8], from 19·8 per 100 000 [19·4-20·3] to 15·3 per 100 000 [15·0-15·6]), and Latino (15·3% [13·3-17·3], from 26·3 per 100 000 [25·6-27·0] to 22·3 per 100 000 [21·8-22·8]) populations and increased in the AIAN (39·3% [32·3-46·4], from 45·6 per 100 000 [40·6-50·6] to 63·5 per 100 000 [57·2-70·2] in 2000 and 2019, respectively) and White (25·8% [24·2-27·3], from 14·7 deaths per 100 000 [14·6-14·9] to 18·5 per 100 000 [18·4-18·7]) populations. In all years, cirrhosis mortality rates were lowest among the Asian population, highest among the AIAN population, and higher in males than females for each racial and ethnic population. The degree of heterogeneity in county-level cirrhosis mortality rates varied by racial and ethnic population, with the narrowest IQR in the Asian population (median 8·0 deaths per 100 000, IQR 6·4-10·4) and the widest in the AIAN population (55·1, 30·3-78·8). Cirrhosis mortality increased over the study period in almost all counties for the White (2957 [96·9%] of 3051 counties) and AIAN (421 [88·8%] of 474) populations, but in a smaller proportion of counties for the Asian, Black, and Latino populations. For all racial and ethnic populations, cirrhosis mortality rates increased in more counties between 2000 and 2015 than between 2015 and 2019.
Cirrhosis mortality increased nationally and in many counties from 2000 to 2019. Although the magnitude of racial and ethnic disparities decreased in some places, disparities nonetheless persisted, and mortality remained high in many locations and communities. Our findings underscore the need to implement targeted and locally tailored programmes and policies to reduce the burden of cirrhosis at both the national and local level.
US National Institutes of Health (Intramural Research Program, National Institute on Minority Health and Health Disparities; National Heart, Lung, and Blood Institute; Intramural Research Program, National Cancer Institute; National Institute on Aging; National Institute of Arthritis and Musculoskeletal and Skin Diseases; Office of Disease Prevention; and Office of Behavioral and Social Sciences Research).
在美国,肝硬化导致了巨大的健康和经济负担。要减轻这一负担,就需要更好地了解肝硬化死亡率在不同种族和族裔以及不同地理位置之间的差异。本研究描述了 2000 年至 2019 年期间,3110 个美国县的五种种族和族裔人群的肝硬化死亡率和趋势。
我们使用先前验证过的小区域估计方法,从美国国家生命统计系统的死亡登记数据和美国国家卫生统计中心的人口数据中,按县、种族和族裔以及年份(2000-19)估计肝硬化死亡率。考虑了五种种族和族裔人群:美洲印第安人或阿拉斯加原住民(AIAN)、亚洲或太平洋岛民(亚裔)、黑种人、拉丁裔或西班牙裔(拉丁裔)和白种人。肝硬化死亡率估计值使用 2010 年美国人口普查的年龄分布作为标准进行年龄标准化。对于每个种族和族裔人群,我们都报告了所有平均年人口大于 1000 的县的估计值。
从 2000 年到 2019 年,全国范围内的肝硬化死亡率在亚裔人群中下降了 23.8%(95%不确定区间为 19.6-27.8%),从每 10 万人 9.4 例(8.9-9.9 例)下降到每 10 万人 7.1 例(6.8-7.5 例);在黑人群体中下降了 22.8%(20.6-24.8%),从每 10 万人 19.8 例(19.4-20.3 例)下降到每 10 万人 15.3 例(15.0-15.6 例);在拉丁裔人群中下降了 15.3%(13.3-17.3%),从每 10 万人 26.3 例(25.6-27.0 例)下降到每 10 万人 22.3 例(21.8-22.8 例);而在 AIAN 人群中增加了 39.3%(32.3-46.4%),从每 10 万人 45.6 例(40.6-50.6 例)增加到每 10 万人 63.5 例(57.2-70.2 例),分别在 2000 年和 2019 年达到最高水平;在白人群体中增加了 25.8%(24.2-27.3%),从每 10 万人 14.7 例(14.6-14.9 例)增加到每 10 万人 18.5 例(18.4-18.7 例)。在所有年份中,肝硬化死亡率在亚裔人群中最低,在 AIAN 人群中最高,并且在每个种族和族裔人群中,男性的死亡率都高于女性。县一级肝硬化死亡率的异质性程度因种族和族裔人群而异,其中亚裔人群的 IQR 最窄(中位数为每 10 万人 8.0 例,IQR 为 6.4-10.4),AIAN 人群的 IQR 最宽(55.1,30.3-78.8)。在白人和 AIAN 人群中,几乎所有县的肝硬化死亡率在研究期间都有所增加(白人 3051 个县中的 2957 个[96.9%],AIAN 474 个县中的 421 个[88.8%]),但在黑人和拉丁裔人群中,只有一部分县的肝硬化死亡率有所增加。对于所有种族和族裔人群,2000 年至 2015 年期间,肝硬化死亡率在更多县上升,而 2015 年至 2019 年期间,肝硬化死亡率在更多县上升。
从 2000 年到 2019 年,全国范围内以及许多县的肝硬化死亡率都有所上升。尽管在某些地方,种族和族裔差异的幅度有所缩小,但差异仍然存在,许多地方和社区的死亡率仍然很高。我们的研究结果强调了需要在国家和地方一级实施有针对性和因地制宜的方案和政策,以减轻肝硬化的负担。
美国国立卫生研究院(内部研究计划,少数民族健康和健康差异研究所;国家心肺血液研究所;内部研究计划,国家癌症研究所;国家老龄化研究所;国家关节炎和肌肉骨骼及皮肤病研究所;疾病预防办公室;和行为与社会科学研究办公室)。